Erratum: Rutin protects against cognitive deficits and brain damage in rats with chronic cerebral hypoperfusion (British Journal of Pharmacology (2015) 171 (3702-3715) DOI: 10.1111/bph.12725);Rutin protects against cognitive deficits and brain damage in rats with chronic cerebral hypoperfusion

British Journal of Pharmacology

Volumn 171, Issue 15, 2014, Pages 3702-3715

  Qu, Jie ^a   Zhou, Qiong ^a   Du, Ying ^a   Zhang, Wei ^a   Bai, Miao ^a   Zhang, Zhuo ^a   Xi, Ye ^a   Li, Zhuyi ^a   Miao, Jianting ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

chronic cerebral hypoperfusion; cognitive deficits; neuroinflammation; oxidative stress; rutin

Indexed keywords

INTERLEUKIN 1BETA; INTERLEUKIN 6; RUTOSIDE; TUMOR NECROSIS FACTOR ALPHA; ACETYLCHOLINE; CYTOKINE; GLUTATHIONE PEROXIDASE; MALONALDEHYDE; NEUROPROTECTIVE AGENT; SUPEROXIDE DISMUTASE;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BILATERAL COMMON CAROTID ARTERY OCCLUSION; BIOCHEMISTRY; BRAIN CORTEX; BRAIN DAMAGE; BRAIN LEVEL; BRAIN PERFUSION; CAROTID ARTERY OBSTRUCTION; CELL ACTIVATION; CHOLINERGIC ACTIVITY; COGNITIVE DEFECT; CONTROLLED STUDY; DRUG MECHANISM; DRUG STRUCTURE; GLIA CELL; HIPPOCAMPUS; HISTOPATHOLOGY; INFLAMMATION; MALE; MENTAL PERFORMANCE; MORRIS WATER MAZE TEST; NERVE CELL LESION; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PASSIVE AVOIDANCE TEST; PRIORITY JOURNAL; RAT; SPATIAL LEARNING; SPATIAL MEMORY; SPRAGUE DAWLEY RAT; T-MAZE TEST; WORKING MEMORY; ANIMAL; ASTROCYTE; AVOIDANCE BEHAVIOR; BRAIN ISCHEMIA; COGNITION DISORDERS; DRUG EFFECTS; MAZE TEST; METABOLISM; MICROGLIA; NERVE CELL; PATHOLOGY;

ACETYLCHOLINE; ANIMALS; ASTROCYTES; AVOIDANCE LEARNING; BRAIN ISCHEMIA; CEREBRAL CORTEX; COGNITION DISORDERS; CYTOKINES; GLUTATHIONE PEROXIDASE; HIPPOCAMPUS; MALE; MALONDIALDEHYDE; MAZE LEARNING; MICROGLIA; NEURONS; NEUROPROTECTIVE AGENTS; OXIDATIVE STRESS; RATS, SPRAGUE-DAWLEY; RUTIN; SUPEROXIDE DISMUTASE;

EID: 84904561502     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/bph.13264     Document Type: Erratum

References (54)

1. Ahmad A, Khan MM, Javed H, Raza SS, Ishrat T, Khan MB, etal. (2012). Edaravone ameliorates oxidative stress associated cholinergic dysfunction and limits apoptotic response following focal cerebral ischemia in rat. Mol Cell Biochem 367: 215-225.
2. Annaházi A, Mracskõ E, Süle Z, Karg E, Penke B, Bari F, etal. (2007). Pre-treatment and post-treatment with alpha-tocopherol attenuates hippocampal neuronal damage in experimental cerebral hypoperfusion. Eur J Pharmacol 571: 120-128.
3. Annapurna A, Ansari MA, Manjunath PM, (2013). Partial role of multiple pathways in infarct size limiting effect of quercetin and rutin against cerebral ischemia-reperfusion injury in rats. Eur Rev Med Pharmacol Sci 17: 491-500.
4. Baskys A, Cheng JX, (2012). Pharmacological prevention and treatment of vascular dementia: approaches and perspectives. Exp Gerontol 47: 887-891.
5. Bossù P, Cutuli D, Palladino I, Caporali P, Angelucci F, Laricchiuta D, etal. (2012). A single intraperitoneal injection of endotoxin in rats induces long-lasting modifications in behavior and brain protein levels of TNF-α and IL-18. J Neuroinflammation 9: 101.
6. Cechetti F, Pagnussat AS, Worm PV, Elsner VR, Ben J, da Costa MS, etal. (2012). Chronic brain hypoperfusion causes early glial activation and neuronal death, and subsequent long-term memory impairment. Brain Res Bull 87: 109-116.
7. Choi BR, Kwon KJ, Park SH, Jeon WK, Han SH, Kim HY, etal. (2011). Alternations of septal-hippocampal system in the adult Wistar rat with spatial memory impairments induced by chronic cerebral hypoperfusion. Exp Neurobiol 20: 92-99.
8. Crichton GE, Bryan J, Murphy KJ, (2013). Dietary antioxidants, cognitive function and dementia-a systematic review. Plant Foods Hum Nutr 68: 279-292.
9. Farkas E, Luiten PG, Bari F, (2007). Permanent, bilateral common carotid artery occlusion in the rat: a model for chronic cerebral hypoperfusion-related neurodegenerative diseases. Brain Res Rev 54: 162-180.
10. Gao YZ, Zhang JJ, Liu H, Wu GY, Xiong L, Shu M, (2013). Regional cerebral blood flow and cerebrovascular reactivity in Alzheimer's disease and vascular dementia assessed by arterial spinlabeling magnetic resonance imaging. Curr Neurovasc Res 10: 49-53.
11. Hanyu H, Sato T, Hirao K, Kanetaka H, Iwamoto T, Koizumi K, (2010). The progression of cognitive deterioration and regional cerebral blood flow patterns in Alzheimer's disease: a longitudinal SPECT study. J Neurol Sci 290: 96-101.
12. Ishrat T, Hoda MN, Khan MB, Yousuf S, Ahmad M, Khan MM, etal. (2009). Amelioration of cognitive deficits and neurodegeneration by curcumin in rat model of sporadic dementia of Alzheimer's type (SDAT). Eur Neuropsychopharmacol 19: 636-647.
13. Javed H, Khan MM, Ahmad A, Vaibhav K, Ahmad ME, Khan A, etal. (2012). Rutin prevents cognitive impairments by ameliorating oxidative stress and neuroinflammation in rat model of sporadic dementia of Alzheimer type. Neuroscience 210: 340-352.
14. Jeon WK, Ma J, Choi BR, Han SH, Jin Q, Hwang BY, etal. (2012). Effects of fructus mume extract on MAPK and NF-κB signaling and the resultant improvement in the cognitive deficits induced by chronic cerebral hypoperfusion. Evid Based Complement Alternat Med 2012: 450838.
15. Kamalakkannan N, Stanely Mainzen Prince P, (2006). Rutin improves the antioxidant status in streptozotocin-induced diabetic rat tissues. Mol Cell Biochem 293: 211-219.
16. Khan MM, Ahmad A, Ishrat T, Khuwaja G, Srivastawa P, Khan MB, etal. (2009). Rutin protects the neural damage induced by transient focal ischemia in rats. Brain Res 1292: 123-135.
17. Khan MM, Raza SS, Javed H, Ahmad A, Khan A, Islam F, etal. (2012). Rutin protects dopaminergic neurons from oxidative stress in an animal model of Parkinson's disease. Neurotox Res 22: 1-15.
18. Kilkenny C, Browne W, Cuthill IC, Emerson M, Altman DG, (2010). Animal research: reporting in vivo experiments: the ARRIVE guidelines. Br J Pharmacol 160: 1577-1579.
19. Koda T, Kuroda Y, Imai H, (2008). Protective effect of rutin against spatial memory impairment induced by trimethyltin in rats. Nutr Res 28: 629-634.
20. Koda T, Kuroda Y, Imai H, (2009). Rutin supplementation in the diet has protective effects against toxicant-induced hippocampal injury by suppression of microglial activation and pro-inflammatory cytokines: protective effect of rutin against toxicant-induced hippocampal injury. Cell Mol Neurobiol 29: 523-531.
21. Kumaran D, Udayabanu M, Kumar M, Aneja R, Katyal A, (2008). Involvement of angiotensin converting enzyme in cerebral hypoperfusion induced anterograde memory impairment and cholinergic dysfunction in rats. Neuroscience 155: 626-639.
22. Kume K, Hanyu H, Sato T, Hirao K, Shimizu S, Kanetaka H, etal. (2011). Vascular risk factors are associated with faster decline of Alzheimer disease: a longitudinal SPECT study. J Neurol 258: 1295-1303.
23. Levine DA, Langa KM, (2011). Vascular cognitive impairment: disease mechanisms and therapeutic implications. Neurother 8: 361-373.
24. Li E, Kim DH, Cai M, Lee S, Kim Y, Lim E, etal. (2011). Hippocampus-dependent spatial learning and memory are impaired in growth hormone-deficient spontaneous dwarf rats. Endocr J 58: 257-267.
25. Li Y, He Y, Guan Q, Liu W, Han H, Nie Z, (2012). Disrupted iron metabolism and ensuing oxidative stress may mediate cognitive dysfunction induced by chronic cerebral hypoperfusion. Biol Trace Elem Res 150: 242-248.
26. McGrath JC, Drummond GB, McLachlan EM, Kilkenny C, Wainwright CL, (2010). Guidelines for reporting experiments involving animals: the ARRIVE guidelines. Br J Pharmacol 160: 1573-1576.
27. Magalingam KB, Radhakrishnan A, Haleagrahara N, (2013). Rutin, a bioflavonoid antioxidant protects rat pheochromocytoma (PC-12) cells against 6-hydroxydopamine (6-OHDA)-induced neurotoxicity. Int J Mol Med 32: 235-240.
28. Meunier J, Ieni J, Maurice T, (2006). The anti-amnesic and neuroprotective effects of donepezil against amyloid beta25-35 peptide-induced toxicity in mice involve an interaction with the sigma1 receptor. Br J Pharmacol 149: 998-1012.
29. Mizoguchi K, Shoji H, Tanaka Y, Maruyama W, Tabira T, (2009). Age-related spatial working memory impairment is caused by prefrontal cortical dopaminergic dysfunction in rats. Neuroscience 162: 1192-1201.
30. Nassiri-Asl M, Mortazavi SR, Samiee-Rad F, Zangivand AA, Safdari F, Saroukhani S, etal. (2010). The effects of rutin on the development of pentylenetetrazole kindling and memory retrieval in rats. Epilepsy Behav 18: 50-53.
31. Nobili F, De Carli F, Frisoni GB, Portet F, Verhey F, Rodriguez G, etal. (2009). SPECT predictors of cognitive decline and Alzheimer's disease in mild cognitive impairment. J Alzheimers Dis 17: 761-772.
32. Peng Y, Xu S, Chen G, Wang L, Feng Y, Wang X, (2007). l-3-n-Butylphthalide improves cognitive impairment induced by chronic cerebral hypoperfusion in rats. J Pharmacol Exp Ther 321: 902-910.
33. Pu F, Mishima K, Irie K, Motohashi K, Tanaka Y, Orito K, etal. (2007). Neuroprotective effects of quercetin and rutin on spatial memory impairment in an 8-arm radial maze task and neuronal death induced by repeated cerebral ischemia in rats. J Pharmacol Sci 104: 329-334.
34. Pyrzanowska J, Piechal A, Blecharz-Klin K, Joniec-Maciejak I, Zobel A, Widy-Tyszkiewicz E, (2012). Influence of long-term administration of rutin on spatial memory as well as the concentration of brain neurotransmitters in aged rats. Pharmacol Rep 64: 808-816.
35. Richetti SK, Blank M, Capiotti KM, Piato AL, Bogo MR, Vianna MR, etal. (2011). Quercetin and rutin prevent scopolamine-induced memory impairment in zebrafish. Behav Brain Res 217: 10-15.
36. Rodrigues AM, Marcilio Fdos S, Frazão Muzitano M, Giraldi-Guimarães A, (2013). Therapeutic potential of treatment with the flavonoid rutin after cortical focal ischemia in rats. Brain Res 1503: 53-61.
37. Ruan CJ, Li Z, Zhang L, Chen DH, Du GH, Sun L, (2010). Protective effects of trans-2, 4-dimethoxystibene on cognitive, impairments induced by Abeta(25-35) in, hypercholesterolemic rats. Brain Res Bull 82: 251-258.
38. Ruitenberg A, den Heijer T, Bakker SL, van Swieten JC, Koudstaal PJ, Hofman A, etal. (2005). Cerebral hypoperfusion and clinical onset of dementia: the Rotterdam Study. Ann Neurol 57: 789-794.
39. Sarkaki A, Rezaiei M, Gharib Naseri M, Rafieirad M, (2013). Improving active and passive avoidance memories deficits due to permanent cerebral ischemia by pomegranate seed extract in female rats. Malays J Med Sci 20: 25-34.
40. Sarti C, Pantoni L, Bartolini L, Inzitari D, (2002). Persistent impairment of gait performances and working memory after bilateral common carotid artery occlusion in the adult Wistar rat. Behav Brain Res 136: 13-20.
41. Schuff N, Matsumoto S, Kmiecik J, Studholme C, Du A, Ezekiel F, etal. (2009). Cerebral blood flow in ischemic vascular dementia and Alzheimer's disease, measured by arterial spin-labeling magnetic resonance imaging. Alzheimers Dement 5: 454-462.
42. Sharma S, Ali A, Ali J, Sahni JK, Baboota S, (2013). Rutin: therapeutic potential and recent advances in drug delivery. Expert Opin Investig Drugs 22: 1063-1079.
43. Staffen W, Schönauer U, Zauner H, Spindler I, Mair A, Iglseder B, etal. (2006). Brain perfusion SPECT in patients with mild cognitive impairment and Alzheimer's disease: comparison of a semiquantitative and a visual evaluation. J Neural Transm 113: 195-203.
44. Tanaka K, Ogawa N, Asanuma M, Kondo Y, Nomura M, (1996). Relationship between cholinergic dysfunction and discrimination learning disabilities in Wistar rats following chronic cerebral hypoperfusion. Brain Res 729: 55-65.
45. Tanaka M, Fukuyama H, Yamauchi H, Narita M, Nabatame H, Yokode M, etal. (2002). Regional cerebral blood flow abnormalities in nondemented patients with memory impairment. J Neuroimaging 12: 112-118.
46. Tongjaroenbuangam W, Ruksee N, Chantiratikul P, Pakdeenarong N, Kongbuntad W, Govitrapong P, (2011). Neuroprotective effects of quercetin, rutin and okra (Abelmoschus esculentus Linn.) in dexamethasone-treated mice. Neurochem Int 59: 677-685.
47. de la Torre JC, (2012). Cerebral hemodynamics and vascular risk factors: setting the stage for Alzheimer's disease. J Alzheimers Dis 32: 553-567.
48. Vicente E, Degerone D, Bohn L, Scornavaca F, Pimentel A, Leite MC, etal. (2009). Astroglial and cognitive effects of chronic cerebral hypoperfusion in the rat. Brain Res 1251: 204-212.
49. Wang SW, Wang YJ, Su YJ, Zhou WW, Yang SG, Zhang R, etal. (2012). Rutin inhibits β-amyloid aggregation and cytotoxicity, attenuates oxidative stress, and decreases the production of nitric oxide and proinflammatory cytokines. Neurotoxicology 33: 482-490.
50. Xi Y, Wang M, Zhang W, Bai M, Du Y, Zhang Z, etal. (2014). Neuronal damage, central cholinergic dysfunction and oxidative damage correlate with cognitive deficits in rats with chronic cerebral hypoperfusion. Neurobiol Learn Mem 109: 7-19.
51. Yamamoto Y, Shioda N, Han F, Moriguchi S, Nakajima A, Yokosuka A, etal. (2009). Nobiletin improves brain ischemia-induced learning and memory deficits through stimulation of CaMKII and CREB phosphorylation. Brain Res 1295: 218-229.
52. Zhang GL, Deng JP, Wang BH, Zhao ZW, Li J, Gao L, etal. (2011). Gypenosides improve cognitive impairment induced by chronic cerebral hypoperfusion in rats by suppressing oxidative stress and astrocytic activation. Behav Pharmacol 22: 633-644.
53. Zhang W, Bai M, Xi Y, Hao J, Liu L, Mao N, etal. (2012a). Early memory deficits precede plaque deposition in APPswe/PS1dE9 mice: involvement of oxidative stress and cholinergic dysfunction. Free Radic Biol Med 52: 1443-1452.
54. Zhang W, Bai M, Xi Y, Hao J, Zhang Z, Su C, etal. (2012b). Multiple inflammatory pathways are involved in the development and progression of cognitive deficits in APPswe/PS1dE9 mice. Neurobiol Aging 33: 2661-2677.